The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
The acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
These re-agent and diagnostic test kits come with 99.7% accuracy
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
Ayush is expanding beyond wellness to therapeutic wellness
Subscribe To Our Newsletter & Stay Updated
